AZ’s COVID-19 vaccine trial ready to resume in US – reports
Chinese City Launches Emergency COVID-19 Vaccine Program; India Outbreak Continues To Slow: Live Updates
Synchronized (still)
Ireland Imposes New Fines For Violating Europe's Most Restrictive Lockdown: Live Updates
India Reports Fewest COVID-19 Cases In 3 Months; Argentina 5th Country To Top 5 Million Cases: Live Updates
ShopUp raises $22.5 million to digitize millions of mom-and-pop shops in Bangladesh
All Eyes on Netflix and Snap Ahead of Earnings; Here's What to Expect
Sustainable Finance Bonds Up 96 Percent YoY
Wisconsin Judge Reinstates COVID-19 Restrictions On Restaurants, Bars: Live Updates
Futures Jump Ahead Of Tuesday Stimulus Deadline
Artemis Accords: why many countries are refusing to sign moon exploration agreement
Global coronavirus cases rise by one-day record of 400,000
The World's Most Bearish Hedge Fund Just Did Something It Hasn't Done In 8 Years
Macro Drivers
Fujifilm seeks approval for Avigan as Covid-19 treatment in Japan
Week Ahead – Time running out for Trump
Sanofi preps trials of second COVID-19 shot, as Russia approves another
France Reports Record 30,000 Cases In 24 Hours As Europe Tops US Tally Yet Again: Live Updates
London Latest To Revive COVID-19 Restrictions As Record Numbers Reported Across Europe: Live Updates
How the needs of monks and empire builders helped mold the modern-day office
S&P Futures Fall, Naz Tumbles On Goldman Tech Downgrade, "Stimulus Pessimism"
Avient Hikes Dividend By 5% On Strong Business
Spain First EU Member To Top 900k COVID-19 Cases; France Revives 'Health Emergency' Order, Imposes Curfews: Live Update
World Mental Health Day — CACTUS releases report of largest researcher mental health survey
Why Saudi Arabia May Be Forced To Start Another Oil Price War
France Imposes COVID-19 'Health Emergency'; Macron Expected To Announce Curfew: Live Update
14/10/20: BRIC: Composite economic activity indicators Q3 results
14/10/20: BRIC: Manufacturing PMIs Q3 results
14/10/20: BRIC: Services PMIs Q3 results
Russia approves second Covid-19 vaccine after preliminary trials